Previous study suggested that dioscin can help ameliorate NAFLD by inhibiting the expression of ACACA, SCD1, and SREBP1 of the liver in HFD-fed mice [40], which is in agreement with our results on the effect of FV treatment. The gene discussed is ACACA; the disease is metabolic dysfunction-associated steatotic liver disease.